retatrutide mechanism triple agonist gip glp-1 glucagon Eli Lilly just announced striking Phase 3 results for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% Retatrutide vs Tirzepatide Compared |

PubMed Central , If you want the RCT yourself: If you want the RCT yourself: If you want the RCT yourself: 18 Lenzi, Andrea, et al

Veggie-loaded frittata Protein: 28g per serving Whisk four eggs with a splash of milk, salt, and pepper

by Pascoe is an effective drug for the treatment of vitamin B12 deficiency that contains hydroxocobalamin as the active form of vitamin B12

When should I avoid taking it

The numbers of prescriptions of GLP-1s have continued to spike from there: Research published by JAMA this year confirms an increase of 503% in male adolescents ages 12 through 17, and a jump of 587.5% in female adolescents between 2020 and 2023

A.et al (2022)